<html>
        <head>
            <link rel="stylesheet" type="text/css" href="layout.css" />
        </head>
        <style> 
            .right { 
                margin-left: 160px;
            } 
        </style>
        
        <div class="sidenav">
            <a href="about.html">About</a>
            <a href="index.html">Index</a>
        </div>
    <div class="header"><h3>Albumin for SBP</h3></div><p><span class="main">"Albumin Infusion in Patients with Cirrhosis and Spontaneous Bacterial Peritonitis".The New England Journal of Medicine. 1999. 341(6):403-409. </span></p><p><span class="contents">
                                        Links to original sources:
                                        <a href=https://www.wikijournalclub.org//wiki/Albumin_for_SBP>Wiki Journal Post</a>
                                        <a href=http://www.nejm.org/doi/full/10.1056/NEJM199908053410603>Full Journal Article</a>
                                        </span></p><p><span class="main">Contents
1Clinical Question
2Bottom Line
3Major Points
4Guidelines
5Design
6Population
6.1Inclusion Criteria
6.2Exclusion Criteria
6.3Baseline Characteristics
7Interventions
8Outcomes
8.1Primary Outcomes
8.2Secondary Outcomes
9Funding
10Further Reading
 </span></p><h2><span class="labels">Clinical Question</span></h2> <hr width="88.5%", align = "right", size="2"><p><span class="main">In patients with cirrhosis and spontaneous bacterial peritonitis, does plasma volume expansion with intravenous albumin prevent renal impairment and reduce mortality?
 </span></p><h2><span class="labels">Bottom Line</span></h2> <hr width="88.5%", align = "right", size="2"><p><span class="main">In patients with cirrhosis and spontaneous bacterial peritonitis, treatment with intravenous albumin in addition to antibiotics significantly decreases the incidence of renal impairment and improves survival compared with antibiotics alone.
 </span></p><h2><span class="labels">Major Points</span></h2> <hr width="88.5%", align = "right", size="2"><p><span class="main">Spontaneous bacterial peritonitis is a severe complication in patients with cirrhosis. One-third of these patients develop renal impairment during the infection despite non-nephrotoxic antibiotic treatment, which is associated with higher mortality. Plasma volume expansion with albumin may enhance arterial blood volume, thus preventing circulatory dysfunction and kidney damage.
 </span></p><h2><span class="labels">Guidelines</span></h2> <hr width="88.5%", align = "right", size="2"><p><span class="main">As of the current knowledge cutoff, the updated guidelines reflecting the results of this study have not been provided.
 </span></p><h2><span class="labels">Design</span></h2> <hr width="88.5%", align = "right", size="2"><p><span class="main">Multicenter, double-blind, randomized, controlled trial.
 </span></p><h2><span class="labels">Population</span></h2> <hr width="88.5%", align = "right", size="2"><p><span class="main">N=126 patients with cirrhosis and spontaneous bacterial peritonitis. 
 </span></p><p><span class="main">Inclusion Criteria
- Polymorphonuclear-cell count in ascitic fluid >250/mm^3
- Age between 18 and 80 years
- Serum creatinine ≤3 mg/dL (265 μmol/L)
 </span></p><p><span class="main">Exclusion Criteria
- Antibiotic treatment within one week before diagnosis
- Other infections, shock, severe hepatic encephalopathy, cardiac failure, organic nephropathy, HIV
- Dehydration causes within one week before diagnosis
 </span></p><p><span class="main">Baseline Characteristics
The groups were well-matched in terms of clinical and laboratory data at enrollment. 
 </span></p><h2><span class="labels">Interventions</span></h2> <hr width="88.5%", align = "right", size="2"><p><span class="main">Two groups: cefotaxime alone (n=63) vs. cefotaxime and intravenous albumin (n=63).
 </span></p><h2><span class="labels">Outcomes</span></h2> <hr width="88.5%", align = "right", size="2"><p><span class="main">Primary Outcomes
- Development of renal impairment
- Mortality during hospitalization and at three months
 </span></p><h2><span class="labels">Outcomes</span></h2> <hr width="88.5%", align = "right", size="2"><p><span class="main">- Resolution of infection 
- Increased plasma renin activity
 </span></p><h2><span class="labels">Funding</span></h2> <hr width="88.5%", align = "right", size="2"><p><span class="main">Supported by grants from the Fondo de Investigación Sanitaria (FIS 94/0956 and FIS 96/1723) and the Hospital Clínic.
 </span></p><h2><span class="labels">Further Reading</span></h2> <hr width="88.5%", align = "right", size="2"><p><span class="main">Original article in The New England Journal of Medicine, 1999. 341(6):403-409. </span></p>    	
        <div class="footer">Footer</div>
        </body>
        </html>